GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » Capex-to-Operating-Cash-Flow

Epitomee Medical (XTAE:EPIT) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Epitomee Medical's Capital Expenditure for the six months ended in Dec. 2024 was ₪-13.90 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2024 was ₪-14.23 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Epitomee Medical Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Epitomee Medical's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical Capex-to-Operating-Cash-Flow Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial 0.02 - - - -

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Epitomee Medical's Capex-to-Operating-Cash-Flow

For the Medical Devices subindustry, Epitomee Medical's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epitomee Medical's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's Capex-to-Operating-Cash-Flow falls into.


;
;

Epitomee Medical Capex-to-Operating-Cash-Flow Calculation

Epitomee Medical's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-16.616) / -29.858
=N/A

Epitomee Medical's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-13.897) / -14.232
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical  (XTAE:EPIT) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Epitomee Medical Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical Business Description

Traded in Other Exchanges
N/A
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical Headlines

No Headlines